Edenred S.A [EDEN] vs Vaziva S.A.S [ALVAZ] Detailed Stock Comparison
Edenred S.A
Euronext
Loading...
Vaziva S.A.S
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Edenred S.A wins in 8 metrics, Vaziva S.A.S wins in 5 metrics, with 0 ties. Edenred S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Edenred S.A | Vaziva S.A.S | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.84 | 106.09 | Edenred S.A |
| Price-to-Book Ratio | N/A | 6.99 | N/A |
| Debt-to-Equity Ratio | -6.61 | 0.06 | Edenred S.A |
| PEG Ratio | 0.14 | N/A | N/A |
| EV/EBITDA | 8.12 | 81.76 | Edenred S.A |
| Profit Margin (TTM) | 18.94% | 3.22% | Edenred S.A |
| Operating Margin (TTM) | 30.47% | -4.71% | Edenred S.A |
| EBITDA Margin (TTM) | 30.47% | N/A | N/A |
| Return on Equity | -62.67% | 6.62% | Vaziva S.A.S |
| Return on Assets (TTM) | 3.92% | 5.00% | Vaziva S.A.S |
| Free Cash Flow (TTM) | $812.00M | N/A | N/A |
| Dividend Yield | 4.85% | N/A | N/A |
| 1-Year Return | -27.93% | 22.61% | Vaziva S.A.S |
| Price-to-Sales Ratio (TTM) | 2.29 | 3.24 | Edenred S.A |
| Enterprise Value | $8.50B | $128.21M | Edenred S.A |
| EV/Revenue Ratio | 3.18 | 3.17 | Vaziva S.A.S |
| Revenue per Share (TTM) | $11 | N/A | N/A |
| Earnings per Share (Diluted) | $2.01 | $0.46 | Edenred S.A |
| Beta (Stock Volatility) | 0.58 | 0.18 | Vaziva S.A.S |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Edenred S.A vs Vaziva S.A.S Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Edenred S.A | 0.74% | 7.59% | -3.71% | -5.09% | -18.69% | -16.78% |
| Vaziva S.A.S | 0.00% | 0.83% | 2.52% | 19.02% | 16.19% | 7.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Edenred S.A | -27.93% | -50.02% | -40.17% | 20.32% | 11.96% | 11.96% |
| Vaziva S.A.S | 22.61% | 121.82% | 121.82% | 121.82% | 121.82% | 121.82% |
Performance & Financial Health Analysis: Edenred S.A vs Vaziva S.A.S
| Metric | EDEN | ALVAZ |
|---|---|---|
| Market Information | ||
| Market Cap | €6.14B | €130.86M |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 547,523 | 279 |
| 90 Day Avg. Volume | 589,886 | 178 |
| Last Close | €25.93 | €48.80 |
| 52 Week Range | €23.92 - €38.57 | €32.40 - €50.50 |
| % from 52W High | -32.77% | -3.37% |
| All-Time High | €62.40 (Jun 12, 2023) | €50.50 (Oct 14, 2024) |
| % from All-Time High | -58.45% | -3.37% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.43% |
| Quarterly Earnings Growth | 0.00% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.03% |
| Operating Margin (TTM) | 0.30% | -0.05% |
| Return on Equity (TTM) | -0.63% | 0.07% |
| Debt to Equity (MRQ) | -6.61 | 0.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-4.87 | €6.98 |
| Cash per Share (MRQ) | €12.49 | N/A |
| Operating Cash Flow (TTM) | €872.00M | €0 |
| Levered Free Cash Flow (TTM) | €382.75M | €1.23M |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.85% | N/A |
| Last 12-Month Dividend | €1.21 | N/A |
Valuation & Enterprise Metrics Analysis: Edenred S.A vs Vaziva S.A.S
| Metric | EDEN | ALVAZ |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.84 | 106.09 |
| Forward P/E | 9.78 | N/A |
| PEG Ratio | 0.14 | N/A |
| Price to Sales (TTM) | 2.29 | 3.24 |
| Price to Book (MRQ) | N/A | 6.99 |
| Market Capitalization | ||
| Market Capitalization | €6.14B | €130.86M |
| Enterprise Value | €8.50B | €128.21M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.18 | 3.17 |
| Enterprise to EBITDA | 8.12 | 81.76 |
| Risk & Other Metrics | ||
| Beta | 0.58 | 0.18 |
| Book Value per Share (MRQ) | €-4.87 | €6.98 |
Financial Statements Comparison: Edenred S.A vs Vaziva S.A.S
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EDEN | ALVAZ |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EDEN | ALVAZ |
|---|---|---|
| Cash & Equivalents | €1.64B | €3.80M |
| Total Current Assets | €8.35B | €9.44M |
| Total Current Liabilities | €9.86B | €3.57M |
| Long-Term Debt | €3.71B | €872,958 |
| Total Shareholders Equity | €-809.00M | €18.57M |
| Retained Earnings | N/A | €1.23M |
| Property, Plant & Equipment | €266.00M | €87,013 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EDEN | ALVAZ |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EDEN | ALVAZ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 547,523 | 279 |
| Average Daily Volume (90 Day) | 589,886 | 178 |
| Shares Outstanding | 240.06M | 2.68M |
| Float Shares | 226.14M | N/A |
| % Held by Insiders | 0.00% | 0.76% |
| % Held by Institutions | 0.83% | 0.00% |
Dividend Analysis & Yield Comparison: Edenred S.A vs Vaziva S.A.S
| Metric | EDEN | ALVAZ |
|---|---|---|
| Last 12-Month Dividend | €1.21 | N/A |
| Last 12-Month Dividend Yield | 4.85% | N/A |
| 3-Year Avg Annual Dividend | €1.10 | N/A |
| 3-Year Avg Dividend Yield | 3.03% | N/A |
| 3-Year Total Dividends | €3.31 | N/A |
| Ex-Dividend Date | Jun 10, 2025 | N/A |